Metastasis-free survival of uveal melanoma by tumour size category based on The Cancer Genome Atlas (TCGA) classification in 1001 cases

Ocular Oncology

Local tumour control and patient survival after ruthenium-106 brachytherapy for small choroidal melanoma

Br J Ophthalmol

Gallo B, Hussain R, Al-Jamal R, Khalid H, Stoker I, Hay G, Arora AK, Szlosarek PW, Sagoo MS

doi: 10.1136/bjo-2023-324687

Ocular Oncology

Higher AJCC stage at primary tumor diagnosis may predict shorter survival in metastatic uveal melanoma

Sci Rep

Yavuzyigitoglu S, Sabazade S, Gill V, Brosens E, Kiliç E, Stålhammar G

doi: 10.1038/s41598-025-03961-1

Ocular Oncology

Increasing Incidence of Posterior Uveal Melanoma in Scandinavia 1960-2022: A Tri-National Study

Am J Ophthalmol

Nissen K, Kiilgaard JF, Fili M, Seregard S, Navaratnam J, Krohn J, Bærland TP, Robsahm TE, Eide N, Stålhammar G

doi: 10.1016/j.ajo.2025.03.002

Ocular Oncology

Validation of Four Prognostic Models for Metastatic Posterior Uveal Melanoma in a Danish Cohort

Invest Ophthalmol Vis Sci

Hindso TG, Bjerrum CW, Nissen K, Sjøl MB, Faber C, Heegaard S, Madsen K, Rosthøj S, Kiilgaard JF

doi: 10.1167/iovs.66.5.38

Ocular OncologyFurther Publications

Advances in primary eye care and ophthalmic imaging contribute to earlier detection of uveal melanoma

Acta Ophthalmol

Bjertnæs V, Hatling AD, Haugen OH, Krohn J

doi: 10.1111/aos.17449

Blindness and Vision ImpairmentOcular OncologySurgery and InterventionCataracts

Association of female sex with cataract surgery in the general population but not in plaque brachytherapy-treated uveal melanoma patients

Sci Rep

Hagström A, Sabazade S, Gill V, Stålhammar G

doi: 10.1038/s41598-024-73346-3

Ocular OncologySurgery and Intervention

Inadvertent Scleral Perforation During Choroidal Melanoma Surgeries: Incidence, Risk Factors, Management, and Outcomes: Scleral Perforation in Melanoma Surgery

Am J Ophthalmol

Chou HD, Heimann H, Damato BE, Hussain RN

doi: 10.1016/j.ajo.2025.05.043

Ocular Oncology

Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis

Surv Ophthalmol

Stålhammar G, Hagström A, Conradi ME, Williams PA

doi: 10.1016/j.survophthal.2024.09.004

Macular DiseasesFurther Publications

Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study

Ophthalmol Sci

Mulyukov Z, Keane PA, Sahni J, Liakopoulos S, Hatz K, Wei Ting DS, Gallego-Pinazo R, Aslam T, Gemmy Cheung CM, De Salvo G, Semoun O, Somfai GM, Stahl A, Lujan BJ, Lorand D

doi: 10.1016/j.xops.2024.100565

Related content

Local tumour control and patient survival after ruthenium-106 brachytherapy for small choroidal melanoma

Higher AJCC stage at primary tumor diagnosis may predict shorter survival in metastatic uveal melanoma

Increasing Incidence of Posterior Uveal Melanoma in Scandinavia 1960-2022: A Tri-National Study

Validation of Four Prognostic Models for Metastatic Posterior Uveal Melanoma in a Danish Cohort

Advances in primary eye care and ophthalmic imaging contribute to earlier detection of uveal melanoma

Association of female sex with cataract surgery in the general population but not in plaque brachytherapy-treated uveal melanoma patients

Inadvertent Scleral Perforation During Choroidal Melanoma Surgeries: Incidence, Risk Factors, Management, and Outcomes: Scleral Perforation in Melanoma Surgery

Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis

Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study